Seystahl, Katharina http://orcid.org/0000-0002-4072-5669
Gramatzki, Dorothee
Wanner, Miriam
Weber, Sung Ju
Hug, Alessia
Luft, Andreas R.
Rohrmann, Sabine
Wegener, Susanne
Weller, Michael
Funding for this research was provided by:
This work was supported by a personal grant (“Filling the gap”) of the University of Zurich, Switzerland and “Walter and Gertrud Siegenthaler Foundation” to KS (no grant number is applicable).
Article History
Received: 17 May 2022
Accepted: 20 December 2022
First Online: 3 January 2023
Competing interests
: AL: honoraria from Moleac, Amgen, Bayer and Daiichi Sankyo. SW: funds by the Swiss National Science Foundation, the UZH Clinical research priority program (CRPP) stroke, the Zurich Neuroscience Center (ZNZ), the Baugarten foundation, speaker honoraria from Amgen, Springer, Teva Pharma, consultancy fee from Bayer and Novartis. MWe: research grants from Apogenix, Merck, Sharp & Dohme, Merck (EMD) and Quercis, honoraria for lectures or advisory board participation or consulting from Adastra, Bristol Meyer Squibb, Medac, Merck, Sharp & Dohme, Merck (EMD), Nerviano Medical Sciences, Novartis, Orbus, Philogen and yMabs. The other authors report no conflicting interests.